We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

News · October 15, 2020

ACS: Tranexamic Acid No Better Than Placebo After Severe Injury

Antifibrinolytic agent may lower 30-day mortality when used within one hour of injury, for severe shock

HealthDay

 

Further Reading